274 related articles for article (PubMed ID: 19433562)
1. NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.
Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Fothergill A; Sutcliffe J
Antimicrob Agents Chemother; 2009 Aug; 53(8):3273-9. PubMed ID: 19433562
[TBL] [Abstract][Full Text] [Related]
2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
3. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor.
Lopes G; Pinto E; Andrade PB; Valentão P
PLoS One; 2013; 8(8):e72203. PubMed ID: 23951297
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
6. The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.
Myc A; Vanhecke T; Landers JJ; Hamouda T; Baker JR
Mycopathologia; 2002; 155(4):195-201. PubMed ID: 12650595
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.
Oyeka CA; Gugnani HC
Mycopathologia; 1990 Jun; 110(3):157-61. PubMed ID: 2388682
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes.
Steinmetz MD; Rascol JP; Régli P; Gargadennec A; Andary C
Mycoses; 1995; 38(7-8):305-9. PubMed ID: 8559195
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the in vitro activity of terbinafine.
Jessup CJ; Ryder NS; Ghannoum MA
Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activities of seven West African Combretaceae used in traditional medicine.
Baba-Moussa F; Akpagana K; Bouchet P
J Ethnopharmacol; 1999 Sep; 66(3):335-8. PubMed ID: 10473181
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
13. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
14. IN VITRO ANTIFUNGAL ACTIVITY OF 2,4-DIHYDROXY-N-(3-THIOXO-3H- 1,2,4-DITHIAZOL-5-YL)BENZENECARBOTHIOAMIDE.
Lukaszuk C; Krajewska-Kulak E; Niewiadomy A; Szynaka B
Acta Pol Pharm; 2016 Nov; 73(6):1511-1519. PubMed ID: 29634105
[TBL] [Abstract][Full Text] [Related]
15. A chemically modified tetracycline (CMT-3) is a new antifungal agent.
Liu Y; Ryan ME; Lee HM; Simon S; Tortora G; Lauzon C; Leung MK; Golub LM
Antimicrob Agents Chemother; 2002 May; 46(5):1447-54. PubMed ID: 11959581
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Activity of Nontoxic Nanocomposite Based on Silver and Reduced Graphene Oxide against Dermatophytes and
Gottardo B; Zoccal ARM; Maschio-Lima T; Lemes TH; Paziani MH; Von Zeska Kress MR; Perfecto TM; Almeida MTG; Volanti DP
ACS Biomater Sci Eng; 2023 Dec; 9(12):6870-6879. PubMed ID: 37943794
[TBL] [Abstract][Full Text] [Related]
17. Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms.
de Matos RF; Mendonça LCV; da Silva Souza KG; Fonseca AAD; Costa EMS; de Lima MVD; Vieira JMDS; de Brito MTFM; Monteiro MC
Folia Microbiol (Praha); 2017 Mar; 62(2):169-174. PubMed ID: 27866353
[TBL] [Abstract][Full Text] [Related]
18. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates.
Carrillo-Muñoz AJ; Fernandez-Torres B; Guarro J
J Chemother; 2003 Dec; 15(6):555-7. PubMed ID: 14998079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
